ALTERATIONS IN ALDOSTERONE SECRETION AND METABOLISM IN LOW RENIN HYPERTENSION

被引:30
作者
GRIFFING, GT
WILSON, TE
MELBY, JC
机构
[1] UNIV HOSP BOSTON, MED CTR, EVANS MEM DEPT CLIN RES, BOSTON, MA 02118 USA
[2] UNIV HOSP BOSTON, MED CTR, DEPT MED, BOSTON, MA 02118 USA
关键词
D O I
10.1210/jcem-71-6-1454
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low renin essential hypertensives (LRH) have normal plasma aldosterone levels which are inappropriately high in relation to their PRA. Posture is the major determinant for plasma aldosterone and PRA levels, but it is not known whether postural increments (Δ) of plasma aldosterone and (Δ) PRA are also abnormal in LRH. To evaluate this, LRH (n = 8), normal renin hypertensives (NRH; n = 9), normotensive controls (n = 18), and subjects with idiopathic hyperaldosteronism (IHA; n = 5) were studied in a metabolic unit on a controlled diet over 7 days. Overnight supine and 4-h upright PRA, plasma aldosterone, and 24-h urinary tetrahydroaldosterone (THA) and aldosterone secretion rates (ASR) were measured. The Δ in plasma aldosterone after 4 h of upright posture was not different in the four groups. The ratio of Δ plasma aldosterone/Δ PRA, however, was elevated in both IHA and LRH compared to that in NRH and normals. THA excretion was also elevated in IHA and LRH, but LRH had a normal ASR. This resulted in a higher fractional THA excretion (THA/ASR) in LRH compared to the other three groups. These data further support enhanced adrenal angiotensin-II sensitivity in LRH. Aldosterone was preferentially metabolized to THA in LRH. Since THA has reduced biological activity, this may be a compensatory mechanism to reduce mineralocorticoid activity in LRH. © 1990 by The Endocrine Society.
引用
收藏
页码:1454 / 1460
页数:7
相关论文
共 47 条
[21]  
KIRENDALL WM, 1976, JAMA-J AM MED ASSOC, V240, P2553
[22]  
KOHL KH, 1978, ACTA ENDOCRINOL-COP, V87, P596, DOI 10.1530/acta.0.0870596
[23]   CONTROL OF ALDOSTERONE SECRETION IN NORMAL AND HYPERTENSIVE MAN - ABNORMAL RENIN-ALDOSTERONE PATTERNS IN LOW RENIN HYPERTENSION [J].
LARAGH, JH ;
SEALEY, J ;
BRUNNER, HR .
AMERICAN JOURNAL OF MEDICINE, 1972, 53 (05) :649-+
[24]  
LONGO DL, 1978, ARCH PATHOL LAB MED, V102, P322
[25]   PRO-GAMMA-MELANOCYTE-STIMULATING HORMONE CLEAVAGE IN ADRENAL-GLAND UNDERGOING COMPENSATORY GROWTH [J].
LOWRY, PJ ;
SILAS, L ;
MCLEAN, C ;
LINTON, EA ;
ESTIVARIZ, FE .
NATURE, 1983, 306 (5938) :70-73
[26]   ENHANCED ADRENAL RESPONSIVENESS TO ANGIOTENSIN-II IN PATIENTS WITH LOW RENIN ESSENTIAL HYPERTENSION [J].
MARKS, AD ;
MARKS, DB ;
KANEFSKY, TM ;
ADLIN, VE ;
CHANNICK, BJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (02) :266-270
[27]   DETERMINATION OF URINARY TETRAHYDROALDOSTERONE GLUCOSIDURONIC ACID BY RADIOIMMUNOASSAY [J].
MATTOX, VR ;
NELSON, AN .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1981, 14 (03) :243-249
[28]   SIMILARITY OF IDIOPATHIC ALDOSTERONISM AND ESSENTIAL-HYPERTENSION - A STATISTICAL COMPARISON [J].
MCAREAVEY, D ;
MURRAY, GD ;
LEVER, AF ;
ROBERTSON, JIS .
HYPERTENSION, 1983, 5 (01) :116-121
[29]   THE METABOLISM OF ALDOSTERONE IN KIDNEY [J].
MCDERMOTT, M ;
LATIF, S ;
MORRIS, DJ .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1983, 19 (02) :1205-1211
[30]   THE METABOLISM AND MECHANISM OF ACTION OF ALDOSTERONE [J].
MORRIS, DJ .
ENDOCRINE REVIEWS, 1981, 2 (02) :234-247